Peptides & the FDA review: your questions, answered

No. The strongest KPV evidence comes from animal and cell studies, most notably a 2008 mouse colitis study. There are no large human trials establishing that KPV is safe and effective for any condition.¹

The FDA-evaluated use listed for KPV is wound healing and inflammatory conditions.²

KPV is not an FDA-approved drug and has no cleared compounding pathway. It was placed in Category 2 of the interim 503A list, then removed in April 2026 and referred to the July 2026 advisory committee. Removal from Category 2 did not add it to the approved list.^{2 3 4}